Patents by Inventor Roger Labrecque
Roger Labrecque has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20060088596Abstract: A method for the provision of a coating on an implantable medical device results in a medical device having a bio-absorbable coating. The coating includes a bio-absorbable carrier component. In addition to the bio-absorbable carrier component, a dissolved therapeutic agent component can also be provided. The coated medical device is implantable in a patient to effect controlled delivery of the coating, including the dissolved therapeutic agent, to the patient.Type: ApplicationFiled: September 28, 2005Publication date: April 27, 2006Applicant: ATRIUM MEDICAL CORPORATIONInventors: Roger Labrecque, Geoffrey Moodie, Lisa Rogers, Joseph Ferraro, Theodore Karwoski, Steve Herweck, Paul Martakos
-
Publication number: 20060083768Abstract: A method for the provision of a coating on an implantable medical device results in a medical device having a bio-absorbable coating. The coating includes a bio-absorbable carrier component. In addition to the bio-absorbable carrier component, a dissolved therapeutic agent component can also be provided. The coated medical device is implantable in a patient to effect controlled delivery of the coating, including the dissolved therapeutic agent, to the patient.Type: ApplicationFiled: September 28, 2005Publication date: April 20, 2006Applicant: ATRIUM MEDICAL CORPORATIONInventors: Roger Labrecque, Geoffrey Moodie, Suzanne Conroy, Lisa Rogers, Joseph Ferraro, Theodore Karwoski, Steve Herweck, Paul Martakos
-
Publication number: 20060067975Abstract: A method of UV curing and corresponding resulting non-polymeric cross-linked gel are provided. The cross-linked gel can be combined with a medical device structure. The cross-linked gel can provide anti-adhesion characteristics, in addition to improved healing and anti-inflammatory response. The cross-linked gel is generally formed of a naturally occurring oil, or an oil composition formed in part of a naturally occurring oil, that is at least partially cured forming a cross-linked gel derived from at least one fatty acid compound. In addition, the oil composition can include a therapeutic agent component, such as a drug or other bioactive agent. The curing method can vary the application of UV light in both intensity and duration to achieve a desired amount of cross-linking forming the gel.Type: ApplicationFiled: September 28, 2005Publication date: March 30, 2006Applicant: ATRIUM MEDICAL CORPORATIONInventors: Roger Labrecque, Philip McNamara, Joseph Ferraro, Lisa Rogers, Paul Martakos, Theodore Karwoski, Steve Herweck, Keith Faucher, Thomas Swanick
-
Publication number: 20060067977Abstract: A method and apparatus for the provision of a coating for application to a medical device results in a medical device having a bio-absorbable coating. The coating includes a bio-absorbable carrier component. In addition to the bio-absorbable carrier component, a therapeutic agent component and solvent can also be provided. The solvent is removed from the coating before the coating is applied to the medical device. The coated medical device is implantable in a patient to effect controlled delivery of the coating, including the therapeutic agent, to the patient.Type: ApplicationFiled: September 28, 2005Publication date: March 30, 2006Applicant: ATRIUM MEDICAL CORPORATIONInventors: Roger Labrecque, Geoffrey Moodie, Joseph Ferraro, Lisa Rogers, Paul Martakos, Theodore Karwoski, Steve Herweck, Suzanne Conroy, Brian Sunter, Georgette Henrich
-
Publication number: 20060067974Abstract: A coated medical device an a method of providing a coating on an implantable medical device result in a medical device having a bio-absorbable coating. The coating includes a bio-absorbable carrier component. In addition to the bio-absorbable carrier component, a therapeutic agent component can also be provided. The coated medical device is implantable in a patient to effect controlled delivery of the coating, including the therapeutic agent, to the patient.Type: ApplicationFiled: September 28, 2005Publication date: March 30, 2006Applicant: ATRIUM MEDICAL CORPORATIONInventors: Roger Labrecque, Geoffrey Moodie, Joseph Ferraro, Lisa Rogers, Paul Martakos, Theodore Karwoski, Steve Herweck
-
Patent number: 6923927Abstract: The invention is directed to methods involving rewetting of expandable polymers with a wettable liquid to allow for enhanced expansion at or below room temperature without breakage, and in some cases, allows one to achieve a greater expansion ratio than that allowed at elevated temperatures using known methods. The wettable liquid can be formed of a drug and/or an agent, such that the resulting polymer contains and emits the drug upon positioning at a target location of a patient body. The expandable polymer can also have the drug or agent added to its structure at a polymer resin preparation stage, through use of an aqueous solution mixed with one or more fluoropolymers, or in a mixing stage. The present invention also allows one to achieve material with unique properties and handling characteristics. These properties included decreased material thickness, increased density, an altered node/fibril morphology, and a more consistent web in the case of flat material.Type: GrantFiled: March 23, 2004Date of Patent: August 2, 2005Assignee: Atrium Medical CorporationInventors: Paul Martakos, Roger Labrecque, Geoffrey Moodie, Steve A. Herweck, Theodore Karwoski
-
Publication number: 20050113687Abstract: A non-polymeric or biological coating applied to porous radially expandable interventional medical devices provides uniform drug distribution and permeation of the coating and any therapeutic agents mixed therewith into a targeted treatment area within the body. The coating is sterile, and is capable of being carried by a sterile medical device to a targeted tissue location within the body following radial expansion. The therapeutic coating transfers off the medical device due in part to a biological attraction with the tissue and in part to a physical transference from the medical device to the targeted tissue location in contact with the medical device. Thus, atraumatic local tissue transference delivery is achieved for uniform therapeutic agent distribution and controlled bio-absorption into the tissue after placement within a patient's body with a non-inflammatory coating.Type: ApplicationFiled: September 15, 2004Publication date: May 26, 2005Inventors: Steve Herweck, Paul Martakos, Geoffrey Moodie, Roger Labrecque, Theodore Karwoski, Trevor Carlton
-
Publication number: 20050106206Abstract: A non-polymeric or biological coating applied to radially expandable interventional medical devices provides uniform drug distribution and permeation of the coating and any therapeutic agents mixed therewith into a targeted treatment area within the body. The coating is sterile, and is capable of being carried by a sterile medical device to a targeted tissue location within the body following radial expansion. The therapeutic coating transfers off the medical device due in part to a biological attraction with the tissue and in part to a physical transference from the medical device to the targeted tissue location in contact with the medical device. Thus, atraumatic local tissue transference delivery is achieved for uniform therapeutic agent distribution and controlled bio-absorption into the tissue after placement within a patient's body with a non-inflammatory coating.Type: ApplicationFiled: September 15, 2004Publication date: May 19, 2005Inventors: Steve Herweck, Paul Martakos, Geoffrey Moodie, Roger Labrecque, Theodore Karwoski, Trevor Carlton
-
Patent number: 6890463Abstract: The invention is directed to methods involving rewetting of expandable polymers with a wettable liquid to allow for enhanced expansion at or below room temperature without breakage, and in some cases, allows one to achieve a greater expansion ratio than that allowed at elevated temperatures using known methods. The wettable liquid can be formed of a drug and/or an agent, such that the resulting polymer contains and emits the drug upon positioning at a target location of a patient body. The present invention also allows one to achieve material with unique properties and handling characteristics. These properties included decreased material thickness, increased density, an altered node/fibril morphology, and a more consistent web in the case of flat material.Type: GrantFiled: April 22, 2002Date of Patent: May 10, 2005Assignee: Atrium Medical CorporationInventors: Paul Martakos, Roger Labrecque, Geoffrey Moodie, Steve A. Herweck, Theodore Karwoski
-
Publication number: 20040253281Abstract: A medical ink is loaded with a number of therapeutic agents. The ink is then applied directly to the tissue of a patient, either internally or externally, resulting in a therapeutic ink marking. The therapeutic ink marking can include surface activation of an immobilizing medication, controlled medication release, and/or the ability to use dyes or pigments to delineate different active ingredients by location and dosage. The active medicinal compounds can be placed on selective areas of the tissue as applied in the marking. The marking can provide a detectable and dosemetric controllable delivery to a specific targeted and localized location to provide the maximum therapeutic benefit. The medicated ink may be applied to a number of different methods. Dimensions of the markings can further serve to control and identify to the user the dosage amount of the medical agent applied to the tissue. Multiple types of medical agents with multiple application methods can be used.Type: ApplicationFiled: June 12, 2003Publication date: December 16, 2004Applicant: ATRIUM MEDICAL CORP.Inventors: Steve A. Herweck, Paul Martakos, Roger Labrecque, Geoffrey Moodie
-
Publication number: 20040253185Abstract: A medical device is loaded with a number of therapeutic agents using a corresponding method to apply a medicated ink mark. The resulting medical device can include surface activation of an immobilizing medication, controlled medication release, and the ability to use dyes or pigments to delineate different active ingredients by location and dosage. The active medicinal compounds can be placed on selective areas of the medical device. The medical device having the medicated ink mark can provide a detectable and dosemetric controllable delivery to a specific targeted and localized location to provide the maximum therapeutic benefit. The medicated ink may be applied to the medical device by a number of different methods, by a manufacturer or by the user at the time of medical device use. Dimensions of the markings printed onto the medical device can further serve to control and identify to the user the dosage amount of the medical agent available on the marked medical device.Type: ApplicationFiled: June 12, 2003Publication date: December 16, 2004Applicant: ATRIUM MEDICAL CORP.Inventors: Steve A. Herweck, Paul Martakos, Roger Labrecque, Geoffrey Moodie
-
Publication number: 20040232587Abstract: The invention is directed to methods involving rewetting of expandable polymers with a wettable liquid to allow for enhanced expansion at or below room temperature without breakage, and in some cases, allows one to achieve a greater expansion ratio than that allowed at elevated temperatures using known methods. The wettable liquid can be formed of a drug and/or an agent, such that the resulting polymer contains and emits the drug upon positioning at a target location of a patient body. The expandable polymer can also have the drug or agent added to its structure at a polymer resin preparation stage, through use of an aqueous solution mixed with one or more fluoropolymers, or in a mixing stage. The present invention also allows one to achieve material with unique properties and handling characteristics. These properties included decreased material thickness, increased density, an altered node/fibril morphology, and a more consistent web in the case of flat material.Type: ApplicationFiled: March 23, 2004Publication date: November 25, 2004Applicant: ATRIUM MEDICAL CORP.Inventors: Paul Martakos, Roger Labrecque, Geoffrey Moodie, Steve A. Herweck, Theodore Karwoski
-
Publication number: 20040236308Abstract: A method of delivering a therapeutic agent to a targeted location within a patient efficiently delivers the agent with a reduced systemic effect. The method includes providing a non-perforated delivery device having at least one wall through which a fluid at first fluid pressure can pass through. The non-perforated delivery device is positioned to provide a radial fluid force against the targeted location. The fluid, including at least one therapeutic agent, is supplied to the therapeutic agent delivery device at the first fluid pressure. The fluid passes through the at least one wall of the delivery device to create a semi-confined space external to the delivery device at a second fluid pressure. The delivery device applies the radial fluid force against the semi-confined space and the fluid disposed therein while simultaneously facilitating the fluid passing through the delivery device to maintain the second fluid pressure in the semi-confined space at the targeted location.Type: ApplicationFiled: May 22, 2003Publication date: November 25, 2004Applicant: ATRIUM MEDICAL CORP.Inventors: Steve A. Herweck, Paul Martakos, Geoffrey Moodie, Roger Labrecque
-
Patent number: 6616876Abstract: The invention is directed to methods involving rewetting of expandable polymers with a wettable liquid to allow for enhanced expansion at or below room temperature without breakage, and in some cases, allows one to achieve a greater expansion ratio than that allowed at elevated temperatures using known methods. The present invention also allows one to achieve material with unique properties and handling characteristics. These properties included decreased material thickness, increased density, an altered node/fibril morphology, and a more consistent web in the case of flat material. This method is not limited to room temperature conditions and can be applied whenever the expandable polymer material is wet with a wettable liquid, and the expansion is performed at a temperature preferably below the vaporization or boiling points of that liquid.Type: GrantFiled: October 3, 2000Date of Patent: September 9, 2003Assignee: Atrium Medical CorporationInventors: Roger Labrecque, Joseph Ferraro, Tom Swanick, Paul Martakos
-
Publication number: 20030153901Abstract: An implantable medical device having a removable polymeric drug delivery panel electrostatically coupled to a surface of a radially expandable structure is provided. The removable polymeric drug delivery panel provides a microporous structure suitable for embedding one or more bioactive agents to allow for kinetic release of the agent or agents at a desired location within a hollow fluid body organ. The removable polymeric drug delivery panel is characterized as having a relatively large and flat surface area to allow for extended or high volumes of kinetic release potential at the site.Type: ApplicationFiled: June 28, 2002Publication date: August 14, 2003Applicant: Atrium Medical CorporationInventors: Steve Herweck, Paul Martakos, Theodore Karwoski, Roger Labrecque
-
Publication number: 20030062650Abstract: The invention is directed to methods involving rewetting of expandable polymers with a wettable liquid to allow for enhanced expansion at or below room temperature without breakage, and in some cases, allows one to achieve a greater expansion ratio than that allowed at elevated temperatures using known methods. The wettable liquid can be formed of a drug and/or an agent, such that the resulting polymer contains and emits the drug upon positioning at a target location of a patient body. The present invention also allows one to achieve material with unique properties and handling characteristics. These properties included decreased material thickness, increased density, an altered node/fibril morphology, and a more consistent web in the case of flat material.Type: ApplicationFiled: April 22, 2002Publication date: April 3, 2003Applicant: ATRIUM MEDICAL CORPORATIONInventors: Paul Martakos, Roger Labrecque, Geoffrey Moodie, Steve A. Herweck, Theodore Karwoski
-
Patent number: 4010232Abstract: A construction panel and a method of making the same wherein a layer of concrete is bound to a layer of urethane or polyurethane through a blanket of dry cement mixture and the in situ setting into a mold of a wet cement mixture and an unset foaming plastic composition. The latter includes urethane or polyurethane, a catalyst, and a blowing agent, the dry cement mixture includes white cement, silica, a coloring agent, and an aggregate, and the concrete is formed from the same dry cement mixture with water.Type: GrantFiled: September 11, 1974Date of Patent: March 1, 1977Inventor: Roger Labrecque